| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 222 | 407 | 504 | 775 |
| Total revenues | 294 | 397 | 920 | NaN |
| Purchases and related costs | 205 | 166 | 245 | NaN |
| Field operating costs | 71 | 69 | 190 | NaN |
| General and administrative expenses | 14 | 11 | 36 | NaN |
| Depreciation and amortization | 0 | 0 | 57 | NaN |
| Losses on asset sales and other, net | -32 | -6 | -15 | NaN |
| Total costs and expenses | 322 | 252 | 543 | NaN |
| Other income, net | NaN | 0 | NaN | NaN |
| Income/(loss) from discontinued operations before tax | -28 | 145 | 377 | NaN |
| Current income tax expense | 44 | 38 | 61 | NaN |
| Deferred income tax expense | 31 | 5 | 35 | NaN |
| Income from discontinued operations, net of tax | NaN | NaN | NaN | 206 |
| (income)/loss from discontinued operations, net of tax | -103 | 102 | 281 | NaN |
| Depreciation and amortization | 243 | 257 | 230 | 466 |
| Gains on asset sales and other, net | 53 | -10 | 93 | -29 |
| Equity-indexed compensation expense | NaN | 50 | NaN | NaN |
| Deferred income tax expense/(benefit) | -208 | 26 | 25 | 40 |
| (gain)/loss on foreign currency revaluation | NaN | 6 | -15 | -4 |
| Settlement of terminated interest rate hedging instruments (note 13) | NaN | -30 | -7 | 0 |
| Change in fair value of preferred distribution rate reset option (note 13) | NaN | 0 | NaN | NaN |
| Equity earnings in unconsolidated entities | 89 | 90 | 96 | 196 |
| Distributions on earnings from unconsolidated entities | 97 | 117 | 113 | 256 |
| Gain on investments in unconsolidated entities, net (note 8, note 9) | NaN | 0 | 0 | 31 |
| Other | -30 | 33 | -16 | -32 |
| Trade accounts receivable and other | NaN | -207 | NaN | NaN |
| Inventory | NaN | -96 | NaN | NaN |
| Trade accounts payable and other | NaN | -337 | NaN | NaN |
| Changes in assets and liabilities, net of acquisitions | -37 | NaN | -158 | 140 |
| Cash provided by operating activities - continuing operations | 400 | 614 | 804 | 1,029 |
| Cash provided by operating activities - discontinued operations | 18 | 170 | 13 | 301 |
| Net cash provided by operating activities | 418 | 784 | 817 | 1,330 |
| Cash paid in connection with acquisitions, net of cash acquired | 88 | 1,786 | 184 | 681 |
| Investments in unconsolidated entities (note 9) | NaN | 2 | 0 | 0 |
| Other investing activities | NaN | NaN | 0 | 0 |
| Additions to property, equipment and other | 130 | 148 | 185 | 310 |
| Cash paid for purchases of linefill | 2 | 10 | 0 | 17 |
| Proceeds from sales of assets | 3 | 54 | 6 | 21 |
| Cash used in investing activities - continuing operations | -217 | -1,892 | -363 | -987 |
| Cash used in investing activities - discontinued operations | -16 | -46 | -45 | -106 |
| Net cash used in investing activities | -233 | -1,938 | -408 | -1,093 |
| Net borrowings under paa commercial paper program (note6) | 116 | 970 | -462 | 69 |
| Repayment under paa epic credit agreement (note 11) | NaN | 1,114 | NaN | NaN |
| Borrowing under paa term loan (note 11) | NaN | 1,100 | NaN | NaN |
| Proceeds from the issuance of paa senior notes (note 11) | NaN | 752 | 1,248 | 998 |
| Repayments of paa senior notes (note 11) | NaN | 1,000 | NaN | NaN |
| Repurchase of common units by a subsidiary | NaN | NaN | 0 | 8 |
| Repurchase of common units by a subsidiary (note 12) | NaN | 8 | NaN | NaN |
| Repurchase of series a preferred units by a subsidiary (note7) | 0 | 0 | 0 | 333 |
| Distributions paid to class a shareholders (note7) | 83 | 76 | 75 | 150 |
| Distributions paid to noncontrolling interests (note7) | 368 | 354 | 356 | 731 |
| Contributions from noncontrolling interests | 0 | 41 | 5 | 29 |
| Other financing activities | -4 | -18 | -42 | -19 |
| Net cash provided by/(used in) financing activities | -339 | 301 | 318 | -145 |
| Effect of translation adjustment - continuing operations | -3 | 1 | 5 | 8 |
| Effect of translation adjustment - discontinued operations | 0 | 0 | -11 | 11 |
| Net increase/(decrease) in cash and cash equivalents and restricted cash | -157 | -852 | 721 | 111 |
| Cash and cash equivalents and restricted cash, beginning of period | 329 | 1,181 | 349 | NaN |
| Cash and cash equivalents and restricted cash, end of period | 172 | 329 | 1,181 | NaN |
PLAINS GP HOLDINGS LP (PAGP)
PLAINS GP HOLDINGS LP (PAGP)